{
    "2020-04-14": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "free insulin",
                        "financial hardship",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Alibaba",
                        "Pfizer",
                        "S&P Global",
                        "Novo Nordisk",
                        "Duke Energy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "finance",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}